A review of current strategies for preventing CIN in at-risk patients

Abstract  Various strategies have been used for the prevention of contrast-induced nephropathy (CIN) in patients at risk. Concurrent use of nephrotoxic medications should be avoided for 24 to 48 h before administration of contrast agents